Plasma levels of angiostatin and endostatin remain unchanged for the first 3 weeks after colorectal cancer surgery (original) (raw)

References

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics. CA Cancer J Clin 59:225–249
    Article PubMed Google Scholar
  2. Bird NC, Mangnall D, Majeed AW (2006) Biology of colorectal liver metastases: a review. J Surg Oncol 94:68–80
    Article PubMed CAS Google Scholar
  3. Allendorf JD, Bessler M, Horvath KD, Marvin MR, Laird DA, Whelan RL (1998) Increased tumor establishment and growth after open vs. laparoscopic bowel resection in mice. Surg Endosc 12:1035–1038
    Article PubMed CAS Google Scholar
  4. Leather AJ, Gallegos NC, Kocjan G, Savage F, Smales CS, Hu W, Boulos PB, Northover JM, Phillips RK (1993) Detection and enumeration of circulating tumour cells in colorectal cancer. Br J Surg 80:777–780
    Article PubMed CAS Google Scholar
  5. Shantha Kumara HMC, Feingold D, Kalady M, Dujovny N, Senagore A, Hyman N, Cekic V, Whelan RL (2009) Colorectal resection is associated with persistent proangiogenic plasma protein changes: postoperative plasma stimulates in vitro endothelial cell growth, migration, and invasion. Ann Surg 249(6):973–977
    Article PubMed Google Scholar
  6. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182–1186
    Article PubMed CAS Google Scholar
  7. Nyberg P, Xie L, Kalluri R (2005) Endogenous inhibitors of angiogenesis. Cancer Res 65:3967–3979
    Article PubMed CAS Google Scholar
  8. O’Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315–328
    Article PubMed Google Scholar
  9. O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277–285
    Article PubMed Google Scholar
  10. O’Reilly MS, Holmgren L, Chen C, Folkman J (1996) Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 2:689–692
    Article PubMed Google Scholar
  11. Sund M, Hamano Y, Sugimoto H, Sudhakar A, Soubasakos M, Yerramalla U, Benjamin LE, Lawler J, Kieran M, Shah A, Kalluri R (2005) Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors. Proc Natl Acad Sci USA 102:2934–2939
    Article PubMed CAS Google Scholar
  12. Sun Y, Wang J, Liu Y, Song X, Zhang Y, Li K, Zhu Z, Zhou Q, You L, Yao C (2005) Results of phase III trial of rh-endostatin (YH-16) in advanced non-small cell lung cancer (NSCLC) patients. J Clin Oncol 23, No 16S (June 1 Supplement) 7138
  13. Sharma MR, Tuszynski GP, Sharma MC (2004) Angiostatin-induced inhibition of endothelial cell proliferation/apoptosis is associated with the down-regulation of cell cycle regulatory protein cdk5. J Cell Biochem 91:398–409
    Article PubMed CAS Google Scholar
  14. Shichiri M, Hirata Y (2001) Antiangiogenic signals by endostatin. FASEB J 15:1044–1053
    Article PubMed CAS Google Scholar
  15. Hanai J, Dhanabal M, Karumanchi SA, Albanese C, Waterman M, Chan B, Ramchandran R, Pestell R, Sukhatme VP (2002) Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1. J Biol Chem 277:16464–16469
    Article PubMed CAS Google Scholar
  16. Troyanovsky B, Levchenko T, Mansson G, Matvijenko O, Holmgren L (2001) Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol 152:1247–1254
    Article PubMed CAS Google Scholar
  17. MacDonald NJ, Shivers WY, Narum DL, Plum SM, Wingard JN, Fuhrmann SR, Liang H, Holland-Linn J, Chen DH, Sim BK (2001) Endostatin binds tropomyosin: a potential modulator of the antitumor activity of endostatin. J Biol Chem 276:25190–25196
    Article PubMed CAS Google Scholar
  18. Dixelius J, Cross Mi, Matsumoto T, Sasaki T, Claseson-Welsh L (2002) Endostatin regulates endothelial cell adhesion and cytoskeletal organization. Cancer Res 62:1944–1947
    PubMed CAS Google Scholar
  19. Chen YH, Wu HL, Li C, Huang YH, Chiang CW, Wu MP, Wu LW (2006) Anti-angiogenesis mediated by angiostatin K1–3, K1–4 and K1–4.5. Involvement of p53, FasL, AKT and mRNA deregulation. Thromb Haemost 95:668–677
    PubMed CAS Google Scholar
  20. Gupta N, Nodzenski E, Khodarev NN, Yu J, Khorasani L, Beckett MA, Kufe DW, Weichselbaum RR (2001) Angiostatin effects on endothelial cells mediated by ceramide and RhoA. EMBO Rep 2:536–540
    PubMed CAS Google Scholar
  21. Dixelius J, Larsson H, Sasaki T, Holmqvist K, Lu L, Engström A, Timpl R, Welsh M, Claesson-Welsh L (2000) Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis. Blood 95:3403–3411
    PubMed CAS Google Scholar
  22. Kang HY, Shim D, Kang SS, Chang SI, Kim HY (2006) Protein kinase B inhibits endostatin-induced apoptosis in HUVECs. J Biochem Mol Biol 39:97–104
    Article PubMed CAS Google Scholar
  23. Dhanabal M, Ramchandran R, Waterman MJ, Lu H, Knebelmann B, Segal M, Sukhatme VP (1999) Endostatin induces endothelial cell apoptosis. J Biol Chem 274:11721–11726
    Article PubMed CAS Google Scholar
  24. Feldman AL, Alexander HR Jr, Bartlett DL, Kranda KC, Miller MS, Costouros NG, Choyke PL, Libutti SK, Feldman AL (2001) A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastases. Ann Surg Oncol 8:741–745
    Article PubMed CAS Google Scholar
  25. Shaarawy M, EI-Sharkawy SA (2001) Biomarker of intrinsic angiogenic and anti-angiogenic activity in patients with endometrial hyperplasia and endometrial cancer. Acta Oncol 40:513–518
    Article PubMed CAS Google Scholar
  26. Feldman AL, Alexander HR Jr, Yang JC, Linehan WM, Eyler RA, Libutti MS (2002) Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma. Cancer 95:1637–1643
    Article PubMed CAS Google Scholar
  27. Zhao J, Yan F, Ju H, Tang J, Qin J (2004) Correlation between serum vascular endothelial growth factor and endostatin levels in patients with breast cancer. Cancer Lett 204:87–95
    Article PubMed CAS Google Scholar
  28. Bjornland K, Buo L, Scott H, Konttinen Y, Johansen HT, Aasen AO (1998) Polymorphonuclear elastase in human colorectal carcinoma. Int J Oncol 12:535–540
    PubMed CAS Google Scholar
  29. Feldman AL, Tamarkin L, Paciotti GF, Simpson BW, Linehan WM, Yang JC, Fogler WE, Turner EM, Alexander HR Jr, Libutti SK (2000) Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer. Clin Cancer Res 6:4628–4634
    PubMed CAS Google Scholar
  30. Kim YM, Hwang S, Kim YM, Pyun BJ, Kim TY, Lee ST, Gho YS, Kwon YG (2002) Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J Biol Chem 277:27872–27879
    Article PubMed CAS Google Scholar
  31. Shantha Kumara HMC, Kirman I, Feingold D, Cekic V, Nasar A, Arnell T, Balik E, Hoffman A, Baxter R, Conte S, Whelan RL (2009) Perioperative GMCSF limits the proangiogenic plasma protein changes associated with colorectal cancer resection. Eur J Surg Oncol 35(3):295–301
    PubMed CAS Google Scholar
  32. Wu FP, Sietses C, von Blomberg BM, van Leeuwen PA, Meijer S, Cuesta MA (2003) Systemic and peritoneal inflammatory response after laparoscopic or conventional colon resection in cancer patients: a prospective, randomized trial. Dis Colon Rectum 46:147–155
    Article PubMed CAS Google Scholar

Download references